Skip to main content
. 2016 Oct 25;8(2):2130–2140. doi: 10.18632/oncotarget.12883

Figure 2. Comparison of matched tissue and plasma mutations.

Figure 2

(A) Percentage of concordant (wild type and mutations) and discordant mutations in matched tissue and plasma samples. (B) Percentage of NSCLC-related driver gene mutations detected in both matched tissue and plasma samples.